Incubation of turkey erythrocytes with the phorbol ester phorbol 12-myristate 13-acetate (PMA) results in a doseand time-dependent desensitization of isoproterenolstimulated adenylate cyclase activity. Compared to controls, membranes from PMA-treated cells have an isoproterenolstimulated adenylate cyclase activity that is decreased 20%-
40%, with little effect on forskolin or fluoride activation of adenylate cyclase. No change in .3-adrenergic receptor number is observed after PMA treatment, indicating that the major effect of PMA is to uncouple receptor interactions with N., the stimulatory guanine nucleotide regulatory protein of adenylate cyclase. Purification of .8-adrenergic receptors from 32P1-labeled turkey erythrocytes, incubated in the presence or absence of PMA, indicates that the phorbol ester is capable of inducing a 3-fold increase in phosphorylation of the /-adrenergic receptor. The PMA effect is similar to the phosphorylation of the .3-adrenergic receptor during isoproterenoland dibutyryl cAMP-induced desensitization of adenylate cyclase in turkey erythrocytes. The findings indicate that decreased receptor-N, coupling is correlated with receptor phosphorylation and that phorbol esters can influence the responsiveness of hormone-sensitive adenylate cyclase in certain cell types.
Phorbol esters, such as phorbol 12-myristate 13-acetate (PMA), are well-known tumor promoting agents that induce a variety of functional and biochemical changes in cells (1) (2) (3) (4) (5) (6) (7) (8) . Several recent reports suggest that the high-affinity binding site for phorbol esters is the Ca2+/phospholipid-dependent protein kinase C (9) (10) (11) . Phorbol esters have also been shown to influence several plasma membrane-associated hormone receptor systems. For example, PMA treatment of cells decreases the affinity of epidermal growth factor (12) (13) (14) (15) (16) (17) and insulin (18) for their respective receptors. Recently, PMA was shown to stimulate the phosphorylation of insulin and somatomedin C receptors (19) .
PMA has been reported to induce a desensitization of isoproterenol-stimulated adenylate cyclase activity in C6 glioma cells (20) and mouse skin and epidermis (21) , although the properties of the desensitization have not been characterized. In this communication, we show that PMA induces phosphorylation of -adrenergic receptors and uncoupling of receptor activation of adenylate cyclase in turkey erythrocytes. The influence of phorbol esters on hormone-sensitive adenylate cyclase and other cell-surface hormone receptors may well be an important component in the action of these compounds.
METHODS

PMA and Isoproterenol-Induced Desensitization of Turkey
Erythrfocytes. Fresh washed turkey erythrocytes in Eagle's minimal essential medium containing 50 mM Hepes (pH 7.4) were incubated 60 min at 370C and then treated with 4 uM PMA or 1 ,uM isoproterenol for 30 min at 370C unless stated otherwise in the figure legends. After chilling and washing, the cells were resuspended in 2 vol of 5 mM Tris HCI/3 mM MgCl2, pH 8.0, and broken by nitrogen cavitation (22) . Membranes isolated from the 15%-40% sucrose interface of sucrose step gradients (100,000 x g; 20 min) were washed twice (35,000 x g; 30 min) in the gradient buffer minus sucrose (20 mM Tris HCl/2 mM EDTA/10 mM MgCl2/100 mM NaCl, pH 8) and stored at -70°C in the same buffer.
32P-Labeling of Turkey Erythrocyte P-Adrenergic Recep-
tor. Turkey erythrocytes were labeled with 32p;, using a modification of the procedure of Alper et al. (23, 24) . Turkey erythrocytes (5-8 ml) were incubated 19 hr at 35-37°C in 25 ml of buffer containing 150 mM NaCl/2.5 mM KCl/11.1 mM glucose/10 mM Hepes/0.05 mM CaCl2/0.1 mM MgCI2, pH 7.4/32p; (0.5-1.0 mCi/ml; 1 Ci = 37 GBq). In control experiments, radioactivity was omitted and 0.2 ,uM NaH2PO4 was added. PMA (10 ,M) or isoproterenol (1 ,aM) was then added and incubation continued for 30 min at 37°C. Subsequent procedures were carried out at 4°C. The cells were then washed 3 times with 30 vol of buffer (150 mM NaCl/2.5 mM KCl/11.1 mM glucose/10 mM Hepes, pH 7.4) followed by a 20-min incubation in 30 vol of lysis buffer (5 MM Tris HCl/2 mM EDTA/5 mM MgCl2, pH 7.4) containing sodium fluoride (1 mM), aprotinin (0.2 units/ml), and phenylmethylsulfonyl fluoride (100 ,ug/ml). After washing twice with 30 vol of lysis buffer containing sodium fluoride, the nucleated ghosts were extracted with 2% digitonin for 60 min at 4°C. R-Adrenergic receptor was purified 1,000tq 4,000-fold by alprenolol Sepharose chromatography in digitonin as described (22) , using bovine serum albumin-treated alprenolol Sepharose; all manipulations were carried out at 4°C. Other Procedures. Photoaffinity labeling using [125I]iodoazidobenzylpindolol (IABP), [1251]iodocyanopindolol (ICYP) binding assays and NaDodSO4/polyacrylamide gel electrophoresis and autoradiography were done as described (22) . Standard concentrations of [125I]IABP and [125I]ICYP used were 1.5 nM and 0.2 nM, respectively. Adenylate cyclase assays were dQne as described (25 [1251]IABP and digitonin were prepared as described (22) . PMA was obtained from P-L Biochemicals. 
RESULTS
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. incubation with PMA or isoproterenol. After a 30-min incubation with either PMA or isoproterenol, there is a significant desensitization of agonist-stimulated adenylate cyclase activity. The approximate 50% decrease in adenylate cyclase stimulation in membranes prepared from isoproterenol-treated turkey erythrocytes is similar to that reported by workers in our laboratory (25) and others (26, 27) for avian erythrocytes. Exposure of turkey erythrocytes to PMA for 30 min resulted in an approximate 30% decrease in isoproterenolstimulated adenylate cyclase activity. The degree of desensitization after PMA treatment was generally about one-half that observed with isoproterenol treatment of the turkey erythrocytes. Table 1 confirms the desensitization of isoproterenol-stimulated adenylate cyclase activity after PMA or isoproterenol treatment of turkey erythrocytes. After pretreatment of cells with either isoproterenol or PMA, the cyclase activity in isolated membranes in the presence of isoproterenol and GTP is significantly decreased, while the isoproterenol-stimulated activity in the presence of guanosine 5'--y-thio]-triphosphate (GTP[S]) is less affected. The ability of forskolin or fluoride to activate adenylate cyclase is slightly, but reproducibly, diminished in membranes prepared from cells incubated with isoproterenol or PMA. This heterologous-type desensitization is somewhat less than reported by others (26, 27) , and it is probably due in part to our relatively short incubation intervals of cells with isoproterenol or PMA. Our data show that a 30-min exposure of intact turkey erythrocytes to isoproterenol or PMA has the primary effect of uncoupling ,¢adrenergic receptor stimulation of adenylate cyclase activity. No effect of isoproterenol or PMA was observed on receptor number (not shown). Fig. 2 shows the time course and dose dependency of the PMA-induced desensitization of isoproterenol-stimulated adenylate cyclase activity. PMA at a relatively high concentration (4 AM) induces a maximal desensitization of isoproterenol-stimulated adenylate cyclase activity within 20 min at 370C with an apparent t112 of 7-8 min. A similar time course for isoproterenol-induced desensitization is also observed (not shown). Exposure of erythrocytes to PMA for 30 min at 370C induces maximal desensitization at 1-4 AM PMA with a half-maximal effect at =100 nM PMA. The dose-response relationship shown here for PMA-induced desensitization of isoproterenol-stimulated adenylate cyclase activity is similar to that for PMA-induced phosphorylation of a Mr 40,000 protein during platelet activation (9) . PMA (1 AM) added directly to control membranes had no effect on adenylate cyclase activity in the presence of isoproterenol and GTP or fluoride, indicating that PMA was not in some way nonspecifically interacting with adenylate cyclase components to decrease agonist stimulation (not shown). Furthermore, the non-tumor-promoting compound 4a-phorbol did not induce desensitization of hormone-sensitive adenylate cyclase at concentrations as high as 10 ,M (not shown).
Our findings indicate that PMA is capable of decreasing the ability of isoproterenol to activate adenylate cyclase. Fig. 3 shows that the presence of 4 ,M PMA during a 30-min treatment of turkey erythrocytes with isoproterenol does not significantly alter the EC50 for isoproterenol-induced desensitization of adenylate cyclase. The maximal desensitization observed with 0.01-10 AM isoproterenol was always greater in the presence of PMA. The difference, however, was consistently less than additive, suggesting that the effects of PMA and isoproterenol are different, but may be affecting a common component of the adenylate cyclase system. Work done in several laboratories (25) (26) (27) (28) (29) indicates the initial event in agonist-induced desensitization is an uncoupling of f3-adrenergic receptor interactions with the stimulatory guanine nucleotide regulatory protein of adenylate cyclase (Nj).
Stadel et al. (30) have also recently demonstrated that isoproterenol-induced desensitization of turkey erythrocytes results in an increased phosphorylation of the -adrenergic receptor. These findings suggest that regulation of coupling between receptor and N, could be regulated by phosphorylation-dephosphorylation mechanisms. Furthermore, a highaffinity receptor for phorbol esters has recently been shown to be the Ca2+/phospholipid-dependent protein kinase C (9-11), suggesting that PMA-induced desensitization may involve a phosphorylation reaction.
Evidence that the ,3-adrenergic receptor is phosphorylated in response to PMA is shown in Fig. 4 . Turkey erythrocytes labeled with 32p, were exposed to PMA or isoproterenol and the receptors were purified on alprenolol-Sepharose. After gel filtration to remove alprenolol, the amount of ,3-adrenergic receptor was quantitated and equal amounts of specific [1251]ICYP binding activity were loaded on NaDodSO4 gels Turkey erythrocytes were treated for 30 min at 370C with 100 AuM isoproterenol (ISO) or PMA (25 Ag/ml), then washed, and membranes were isolated. Adenylate cyclase activity was then measured in the presence of various combinations of 10 and electrophoresed. Autoradiograms of the NaDodSO4 gels, containing equal amounts of specific receptor binding, show a significant increase in the phosphorylation of a Mr 39,000 peptide in response to both PMA and isoproterenol. The Mr 39,000 peptide corresponds to the same Mr as the major form of the /3-adrenergic receptor purified from turkey erythrocytes (22, 30, 31) . A second receptor peptide of Mr 52,000, which is variable in amount in different preparations (22, 30, 31) , was not abundant after purification of the /3adrenergic receptor in these two experiments. Thus, both PMA and isoproterenol induce desensitization of adenylate cyclase and phosphorylation of the Mr 39,000 /3-adrenergic receptor peptide. Quantitation of the receptor phosphorylation in response to PMA and isoproterenol is shown in Ta- Evidence that the Mr 39,000 peptide whose phosphorylation is enhanced by both PMA and isoproterenol, is in fact the f-adrenergic receptor, is shown in Fig. SA . It has been previously demonstrated that the f3-adrenergic receptor photoaffinity probe [1251]IABP specifically labels a predominant Mr 39,000 peptide and a Mr 52,000 peptide of low abundance in turkey erythrocyte membranes and with the alprenolol-Sepharose purified receptor (22) . Photolabeling of both pep- Further evidence that the phosphorylated Mr 39,000 and Mr 52,000 bands are the 8-adrenergic receptor is shown in Fig. 5B . ,3-Adrenergic receptors from 32P-labeled turkey erythrocytes were purified on an alprenolol-Sepharose column. The fraction eluted from the affinity column by alpren- Proc. NatL Acad ScL USA 81 (1984) olol was chromatographed on a Sephadex G-50 column to remove the alprenolol, and void volume fractions were assayed for specific [1251]ICYP binding or run on NaDodSO4 gels and autoradiographed. Specific [1251]ICYP binding corresponds to 0.1, 1.3, 1.8, and 1.0 fmol (lanes 1-4, respectively). There is a positive correlation of ['251]ICYP binding and purification of the phosphorylated Mr 39,000 and Mr 52,000 peptides. By several criteria, including specific elution by alprenolol, photolabeling of the phosphorylated peptides analyzed on NaDodSO4 gels (Fig. 5A) , and specific binding with [1251]-ICYP in fractions eluted from a gel filtration column (Fig. SB) indicate, that the phosphorylated peptides are ,3adrenergic receptor ligand binding proteins.
DISCUSSION
Our findings demonstrate two effects of PMA: (i) desensitization of isoproterenol activation of adenylate cyclase and (ii) increased phosphorylation of the ,3-adrenergic receptor. The results also support the findings of Stadel et al. (30) that isoproterenol-induced desensitization of adenylate cyclase in turkey erythrocytes results in phosphorylation of the 1adrenergic receptor. Phorbol ester-induced effects on the hormone-sensitive adenylate cyclase system may be a general phenomenon. PMA induces desensitization of hormonestimulated adenylate cyclase in turkey erythrocytes (this report), C6 glioma (20) , and mouse skin and epidermis (21) . We have preliminary evidence that phorbol esters alter the regulation of hormone-sensitive adenylate cyclase in A431 human carcinoma cells (unpublished data).
The PMA-induced desensitization that we observe in turkey erythrocytes is similar in magnitude to the desensitization observed with dibutyryl cAMP (26) . However, our studies in turkey erythrocytes and those of others in different cell types (32) suggest no major or consistent effect of PMA on increasing cAMP levels. We have also found that the 3-adrenergic receptor in membranes or purified in a soluble or liposome reconstituted form is a poor substrate for the purified catalytic subunit of cAMP-dependent protein kinase from bovine heart (unpublished observation). The work of Stadel et al. (30) also suggested the ,3adrenergic receptor is a poor substrate for cAMP-dependent protein kinase. Using a genetic approach, two other independent lines of evidence suggest that activation of cAMP-dependent protein kinase does not have to occur during desensitization. Shear et al. (33) , using a cAMP-dependent protein kinase-deficient mutant (kin-) of S49 mouse lymphoma cells, demonstrated that isoproterenol-induced desensitization is essentially identical in the kinmutants compared to wild-type cells. Green and Clark (34) , using membrane reconstitution procedures, also demonstrated isoproterenol-induced desensitization in cyc-S49 mutants, which lack a functional N, protein and do not activate adenylate cyclase in response to isoproterenol. How then could desensitization of hormone-sensitive adenylate cyclase occur in the turkey erythrocyte? It is tempting to hypothesize that protein kinase C is involved; however, our data do not demonstrate that protein kinase C phosphorylates the ,B-adrenergic receptor. Certainly, other kinases or phosphatases may be involved in the change in phosphorylation state of the receptor. The correlation between phosphorylation of the /3-adrenergic receptor and desensitization by PMA, isoproterenol, and dibutyryl cAMP is compelling evidence to hypothesize that this is an important mechanism to regulate receptor-N, coupling. Phosphorylation of the receptor at two different sites, depending on agonist occupancy and the resulting conformation of the receptor, could explain the partial desensitization observed with PMA compared to isoproterenol.
Agonist-induced desensitization of adenylate cyclase is admittedly different in turkey erythrocytes compared to many other cell types. Most notably is the failure of P-adrenergic receptors to be internalized by turkey erythrocytes during desensitization. In other cell types, internalization of receptors appears to be a component of the desensitization process for hormone-sensitive adenylate cyclase. Since phosphorylation of the ,B-adrenergic receptor has been observed only in the turkey erythrocyte, the question that arises is whether receptor phosphorylation is unique to the avian erythrocyte. We are not aware of any reports that di-rectly address this question. There are several studies that may bear on this question indirectly. Birnbaumer and coworkers (35, 36) and others (37, 38) have described isolated membrane systems in which agonist-induced uncoupling of receptor-N, interactions could be observed. The decreased efficiency of receptor-N, coupling usually required ATP, was receptor mediated, and imidodiphosphate analogs of ATP could not induce the uncoupling. The data suggest that receptor-N, uncoupling might be mediated by phosphorylation, and furthermore, cAMP is not required. In many respects, the degree of agonist-induced uncoupling of receptor-N, interactions in these mammalian membrane preparations is similar to the desensitization phenomenon observed in avian erythrocytes. Therefore, phosphorylation of receptors could conceivably be an early step in agonist-induced desensitization of adenylate cyclase in many cell types. Endocytosis of the receptor could result in rapid dephosphorylation due to phosphatases present in the cytoplasm of the cell, making detection of phosphorylated receptor difficult. The ability to purify components and reconstitute receptor-Ns interactions in liposomes (22, 39, 40) or cells (41, 42) should allow us to develop in vitro systems to directly address the questions of phosphorylation and the regulation of receptor-Ns interactions. 
